Ligand Pharmaceuticals Inc. (LGND)
NASDAQ · Healthcare
Ligand Pharmaceuticals Inc. Operating Income 2009–2025
Ligand Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Ligand Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was 17.4 M, a 147.96% decrease year-over-year.
- Ligand Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was 44.5 M, a 550.18% decrease year-over-year.
- Ligand Pharmaceuticals Inc. annual operating income for 2025 was 41.0 M, a 281.38% decrease from 2024.
- Ligand Pharmaceuticals Inc. annual operating income for 2024 was -22.6 M, a 289.30% decrease from 2023.
- Ligand Pharmaceuticals Inc. annual operating income for 2023 was 11.9 M, a 293.22% increase from 2022.
- Ligand Pharmaceuticals Inc. annual operating income for 2022 was 3.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ligand Pharmaceuticals Inc. Operating Income — FAQ
Ligand Pharmaceuticals Inc. (LGND) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Ligand Pharmaceuticals Inc.'s operating income?
Ligand Pharmaceuticals Inc. (LGND) reported operating income of $41M for fiscal 2025.
Where can I see LGND's operating income history?
The chart and table above show Ligand Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.